Small-molecule-induced ERBB4 activation to treat heart failure
Source
Nature communications - ISSN 2041-1723-16:1 (2025) p. 1-19
AI is a viable alternative to high throughput screening : a 318-target study
Source
Scientific reports - ISSN 2045-2322-14:1 (2024) p. 1-16
Cardiovascular toxicities of immune therapies for cancer : a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology
Source
European journal of heart failure - ISSN 1388-9842-26:10 (2024) p. 2055-2076
ERBB4 stimulation as a therapeutic strategy for atrial myopathy and atrial fibrillation
Source
Antwerpen, Universiteit Antwerpen, Faculteit Geneeskunde en Gezondheidswetenschappen, 2024,195 p.
Pathophysiology and clinical relevance of atrial myopathy
Source
Basic research in cardiology - ISSN 0300-8428-119:2 (2024) p. 215-242